Media

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

https://investor.ironwoodpharma.com/press-releases/press-release-details/2009/Ironwood-And-Forest-Present-Additional-Positive-Phase-2b-Study-Results-For-Linaclotide-In-Patients-With-Irritable-Bowel-Syndrome-With-Constipation/default.aspx

Ironwood has successfully completed the tender offer of VectivBio, a global clinical-stage biotechnology company
pioneering novel, transformational treatments for severe rare gastrointestinal conditions. For more information, click here